Lv1
30 积分 2024-05-20 加入
Preferential tumor targeting of HER2 by iPSC-derived CAR T cells engineered to overcome multiple barriers to solid tumor efficacy
1个月前
已完结
BCMA biology and therapeutic targeting in multiple myeloma: From ligand signaling to antigen escape
3个月前
已完结
Multiple myeloma
3个月前
已完结
Forks in the road for CAR T and CAR NK cell cancer therapies
5个月前
已完结
Human pluripotent stem cell-derived innate and adaptive immune cells for cancer immunotherapy
5个月前
已完结
The GDNF family: Signalling, biological functions and therapeutic value
6个月前
已完结
Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma
6个月前
已完结
CAR-macrophage therapy for HER2-overexpressing advanced solid tumors: a phase 1 trial
6个月前
已完结
Chimeric Antigen Receptor Therapy
6个月前
已完结
Adoptive cell transfer as personalized immunotherapy for human cancer
6个月前
已完结
皖公网安备34019202002308
